In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $8.22 in the prior trading day, Pediatrix Medical Group Inc (NYSE: MD) closed at $8.53, up 3.77%. In other words, the price has increased by $3.77 from its previous closing price. On the day, 1.11 million shares were traded. MD stock price reached its highest trading level at $8.685 during the session, while it also had its lowest trading level at $8.23.
Ratios:
Our goal is to gain a better understanding of MD by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.38. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 2.06. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.91.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, SVB Leerink on September 27, 2021, initiated with a Mkt Perform rating and assigned the stock a target price of $29.
Deutsche Bank Downgraded its Hold to Sell on October 19, 2020, whereas the target price for the stock was revised from $20 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 14 ’23 when Swift James D sold 5,764 shares for $9.58 per share. The transaction valued at 55,219 led to the insider holds 90,874 shares of the business.
Moore Mary Ann E sold 1,150 shares of MD for $11,063 on Dec 14 ’23. The EVP, General Counsel & Sec now owns 15,730 shares after completing the transaction at $9.62 per share. On Dec 14 ’23, another insider, Moore Mary Ann E, who serves as the EVP, General Counsel & Sec of the company, sold 970 shares for $9.62 each. As a result, the insider received 9,331 and left with 81,385 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 717775616 and an Enterprise Value of 1369391872. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.36 while its Price-to-Book (P/B) ratio in mrq is 0.74. Its current Enterprise Value per Revenue stands at 0.685 whereas that against EBITDA is 7.218.
Stock Price History:
Over the past 52 weeks, MD has reached a high of $15.02, while it has fallen to a 52-week low of $7.70. The 50-Day Moving Average of the stock is -7.02%, while the 200-Day Moving Average is calculated to be -19.55%.
Shares Statistics:
The stock has traded on average 739.15K shares per day over the past 3-months and 918100 shares per day over the last 10 days, according to various share statistics. A total of 84.15M shares are outstanding, with a floating share count of 83.34M. Insiders hold about 0.95% of the company’s shares, while institutions hold 102.04% stake in the company. Shares short for MD as of 1714435200 were 4672866 with a Short Ratio of 6.32, compared to 1711584000 on 4120422. Therefore, it implies a Short% of Shares Outstanding of 4672866 and a Short% of Float of 7.920000000000001.
